292 related articles for article (PubMed ID: 34278485)
1. FOXG1 improves mitochondrial function and promotes the progression of nasopharyngeal carcinoma.
Xi H; He Z; Lv C
Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34278485
[TBL] [Abstract][Full Text] [Related]
2. Amyloid β precursor protein silencing attenuates epithelial‑mesenchymal transition of nasopharyngeal carcinoma cells via inhibition of the MAPK pathway.
Xu J; Ying Y; Xiong G; Lai L; Wang Q; Yang Y
Mol Med Rep; 2019 Jul; 20(1):409-416. PubMed ID: 31180550
[TBL] [Abstract][Full Text] [Related]
3. Opa interacting protein 5 promotes metastasis of nasopharyngeal carcinoma cells by promoting EMT via modulation of JAK2/STAT3 signal.
Zheng YQ; Cui YR; Yang S; Wang YP; Qiu YJ; Hu WL
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):613-621. PubMed ID: 30720169
[TBL] [Abstract][Full Text] [Related]
4. FOXD3 inhibits cell proliferation, migration, and invasion in nasopharyngeal carcinoma through regulation of the PI3K-Akt pathway.
Xie X; Xiong G; Chen W; Fu H; Li M; Cui X
Biochem Cell Biol; 2020 Dec; 98(6):653-660. PubMed ID: 32459973
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells.
Qiao N; Wang L; Wang T; Li H
Tumour Biol; 2016 Jun; 37(6):8169-79. PubMed ID: 26715277
[TBL] [Abstract][Full Text] [Related]
6. High SRC-1 and Twist1 expression predicts poor prognosis and promotes migration and invasion by inducing epithelial-mesenchymal transition in human nasopharyngeal carcinoma.
Zhou J; Zhang J; Xu M; Ke Z; Zhang W; Mai J
PLoS One; 2019; 14(4):e0215299. PubMed ID: 30973923
[TBL] [Abstract][Full Text] [Related]
7. MALAT1/miR-124/Capn4 axis regulates proliferation, invasion and EMT in nasopharyngeal carcinoma cells.
Shi B; Wang Y; Yin F
Cancer Biol Ther; 2017 Oct; 18(10):792-800. PubMed ID: 28857668
[TBL] [Abstract][Full Text] [Related]
8. MiRNA-506 presents multiple tumor suppressor activities by targeting EZH2 in nasopharyngeal carcinoma.
Fan DC; Zhao YR; Qi H; Hou JX; Zhang TH
Auris Nasus Larynx; 2020 Aug; 47(4):632-642. PubMed ID: 31932074
[TBL] [Abstract][Full Text] [Related]
9. FOXD1, negatively regulated by miR-186, promotes the proliferation, metastasis and radioresistance of nasopharyngeal carcinoma cells.
Zhang Y; Zhang W
Cancer Biomark; 2020; 28(4):511-521. PubMed ID: 32568181
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA‑19b inhibitors can attenuate the STAT3 signaling pathway in NPC C666‑1 cells.
Bian LH; Duan JL; Zhou C; Shen GW; Wang XY; Yang Y; Zhang XL; Xiao SJ
Mol Med Rep; 2020 Jul; 22(1):51-56. PubMed ID: 32377721
[TBL] [Abstract][Full Text] [Related]
11. miR‑182‑5p contributes to radioresistance in nasopharyngeal carcinoma by regulating BNIP3 expression.
He W; Jin H; Liu Q; Sun Q
Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33313953
[TBL] [Abstract][Full Text] [Related]
12. Forkhead box C1 induces epithelial‑mesenchymal transition and is a potential therapeutic target in nasopharyngeal carcinoma.
Ou-Yang L; Xiao SJ; Liu P; Yi SJ; Zhang XL; Ou-Yang S; Tan SK; Lei X
Mol Med Rep; 2015 Dec; 12(6):8003-9. PubMed ID: 26461269
[TBL] [Abstract][Full Text] [Related]
13. MircoRNA-629 promotes proliferation, invasion and migration of nasopharyngeal carcinoma through targeting PDCD4.
Zheng YQ; Bai YF; Yang S; Cui YR; Wang YP; Hu WL
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):207-216. PubMed ID: 30657562
[TBL] [Abstract][Full Text] [Related]
14. Function of AXL and molecular mechanisms in regulation of nasopharyngeal carcinoma.
Zhou K; Zhao J; Xu H; Yan X; Liu W; Jiang X; Ren C
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jun; 47(6):685-697. PubMed ID: 35837768
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of p62 Induces Autophagy and Promotes Proliferation, Migration and Invasion of Nasopharyngeal Carcinoma Cells through Promoting ERK Signaling Pathway.
Wu Q; Xiang M; Wang K; Chen Z; Long L; Tao Y; Liang Y; Yan Y; Xiao Z; Qiu S; Yi B
Curr Cancer Drug Targets; 2020; 20(8):624-637. PubMed ID: 32329689
[TBL] [Abstract][Full Text] [Related]
16. FBXL19‑AS1 promotes the progression of nasopharyngeal carcinoma by acting as a competing endogenous RNA to sponge miR‑431 and upregulate PBOV1.
Dong H; Huang C; Huang J
Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34278444
[TBL] [Abstract][Full Text] [Related]
17. LncRNA ZFAS1 promotes proliferation and migration and inhibits apoptosis in nasopharyngeal carcinoma via the PI3K/AKT pathway in vitro.
Wang X; Jin Q; Wang X; Chen W; Cai Z
Cancer Biomark; 2019; 26(2):171-182. PubMed ID: 31403940
[TBL] [Abstract][Full Text] [Related]
18. The inhibition of tumor protein p53 by microRNA-151a-3p induced cell proliferation, migration and invasion in nasopharyngeal carcinoma.
Liu H; Cheng Y; Xu Y; Xu H; Lin Z; Fan J; Lang J
Biosci Rep; 2019 Oct; 39(10):. PubMed ID: 31652456
[TBL] [Abstract][Full Text] [Related]
19. Targeting FoxM1 inhibits proliferation, invasion and migration of nasopharyngeal carcinoma through the epithelial‑to-mesenchymal transition pathway.
Yu C; Chen L; Yie L; Wei L; Wen T; Liu Y; Chen H
Oncol Rep; 2015 May; 33(5):2402-10. PubMed ID: 25738652
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-296-5p inhibits cell metastasis and invasion in nasopharyngeal carcinoma by reversing transforming growth factor-β-induced epithelial-mesenchymal transition.
Chen M; Chen C; Luo H; Ren J; Dai Q; Hu W; Zhou K; Tang X; Li X
Cell Mol Biol Lett; 2020 Nov; 25(1):49. PubMed ID: 33292168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
